Delta Syndrome

Drug Name: Joenja Indications: To treat activated phosphoinositide 3-kinase delta syndrome. Active Ingredient: Leniolisib Company: Pharming Intellectual Property B.V. Approval Date: 3/24/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217759s000lbl.pdf